Using ¹⁸F-Fluciclovine PET/CT to Detect Prostate Cancer Recurrence in Patients With Very Low PSA Levels

Using 18F-Fluciclovine PET/CT to Detect Prostate Cancer Recurrence in Patients With Very Low PSA LevelsBarry A. Siegel, MD1B. A. Siegel is a consultant for Avid Radiopharmaceuticals, Inc.; Capella Imaging, Inc.; Curium Pharma, Inc.; ImaginAb, Inc.; and Progenics Pharmaceuticals, Inc.; has served on advisory boards for Blue Earth Diagnostics and GE Healthcare; and has received clinical trial support from Blue Earth Diagnostics; ImaginAb, Inc.;...